{
    "organizations": [],
    "uuid": "a4cf26b83456fe6f922f1f3ce98da968a8179a25",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-recipharm-q1-ebitda-up-at-sek-250/brief-recipharm-q1-ebitda-up-at-sek-250-million-idUSFWN1S40GV",
    "ord_in_thread": 0,
    "title": "BRIEF-Recipharm Q1 EBITDA Up At SEK 250 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - RECIPHARM AB (PUBL):\n* Q1 EBITDA SEK 250 MILLION VERSUS SEK 159 MILLION YEAR AGO\n* Q1 NET SALES SEK 1.51 BILLION VERSUS SEK 1.33 BILLION YEAR AGO\n* JAN-MARCH OPERATING PROFIT (EBIT) AMOUNTED TO SEK 120 MILLION (46) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-27T13:48:00.000+03:00",
    "crawled": "2018-04-28T12:55:05.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "recipharm",
        "ab",
        "publ",
        "q1",
        "ebitda",
        "sek",
        "million",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "q1",
        "net",
        "sale",
        "sek",
        "billion",
        "versus",
        "sek",
        "billion",
        "year",
        "ago",
        "operating",
        "profit",
        "ebit",
        "amounted",
        "sek",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}